Acute liver injury (ALI) is one of the most prevalent liver diseases, which have become a major health threat worldwide. Here, the meaning of this research is to explore the ability of L. rhamnosus FJG1530 to alleviate ALI in mice. In this study, L. rhamnosus FJG1530 alleviated lipopolysaccharide (LPS)-induced ALI symptoms, including elevated transaminase (aspartate aminotransferase [AST], and alanine aminotransferase [ALT]) levels, liver tissue damage, increased liver oxidative stress (superoxide dismutase [SOD], catalase [CAT], glutathione [GSH], and total antioxidant capacity [T-AOC]), and high concentration of inflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-1β [IL-1β], and interleukin-6 [IL-6]). Additionally, the mice treated with L. rhamnosus FJG1530 showed an upward trend in short-chain fatty acid content in the cecum, and alteration of the gut microbiota structure. The study also discovered that L. rhamnosus FJG1530 intervention improved the composition of liver metabolites, and these characteristic biomarkers mainly involving galactose metabolism, histidine metabolism, ascorbate and aldarate metabolism etc. In summary, L. rhamnosus FJG1530 has the ability to prevent the occurrence of ALI through impairing the inflammatory response, curbing liver oxidative stress, and adjusting the gut microbiota structure.
扫码关注我们
求助内容:
应助结果提醒方式:
